Highlights •Prognosis of ALK-positive NSCLC patients has dramatically improved over last decade. • Patients with ALK-positive NSCLC are at increased risk of coagulation disorders. • We reported a rapidly evolving DIC as presentation of ALK-positive NSCLC. • Admission to ICU should be considered for patients with ALK-positive NSCLC. • The association between ALK-rearrangement and VTE should be assessed prospectively.
De Giglio A., Porreca R., Brambilla M., Metro G., Prosperi E., Bellezza G., et al. (2018). Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?. THROMBOSIS RESEARCH, 163, 51-53 [10.1016/j.thromres.2017.12.004].
Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?
De Giglio A.;Ricciuti B.
2018
Abstract
Highlights •Prognosis of ALK-positive NSCLC patients has dramatically improved over last decade. • Patients with ALK-positive NSCLC are at increased risk of coagulation disorders. • We reported a rapidly evolving DIC as presentation of ALK-positive NSCLC. • Admission to ICU should be considered for patients with ALK-positive NSCLC. • The association between ALK-rearrangement and VTE should be assessed prospectively.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
